| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
GB:ONT
Oxford Nanopore Technologies PLC
|
Aug 27, 2026 | BUY |
Strong Buy
+16.2% avg upside
7 analysts
|
$220.00
24.18% Upside
|
-1.0% | · |
|
ZLDPF
Zealand Pharma
|
Mar 11, 2026 | BUY |
Buy
+87.0% avg upside
12 analysts
|
$70.68
64.39% Upside
|
+8.1% | · |
|
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
|
Dec 08, 2025 | BUY |
Hold
-2.0% avg upside
9 analysts
|
$70.00
32.53% Upside
|
+11.2% | · |
|
GB:GSK
GlaxoSmithKline
|
Sep 18, 2025 | SELL |
Hold
+2.9% avg upside
26 analysts
|
$1400.00
25.95% Downside
|
-25.5% | · |
|
CH:SDZ
Sandoz Group Ltd
|
Sep 16, 2025 | BUY |
Buy
-2.6% avg upside
12 analysts
|
$55.00
22.27% Downside
|
+43.5% | · |
|
GB:0QW0
arGEN X
|
Aug 26, 2025 | BUY |
Strong Buy
-27.2% avg upside
25 analysts
|
$730.00
16.26% Downside
|
· | · |
|
GB:HIK
Hikma Pharmaceuticals
|
Aug 08, 2025 | BUY |
Strong Buy
+49.9% avg upside
9 analysts
|
$2500.00
54.97% Upside
|
-5.9% | · |
|
ARGX
Argenx Se
|
Aug 04, 2025 | BUY |
Strong Buy
-14.2% avg upside
48 analysts
|
$830.00
15.92% Downside
|
+22.3% | · |
|
GB:AZN
AstraZeneca
|
Jul 29, 2025 | BUY |
Strong Buy
+19.2% avg upside
27 analysts
|
$14000.00
11.17% Upside
|
+10.7% | · |
|
CH:GALD
Galderma Group AG
|
Jul 25, 2025 | BUY |
Strong Buy
+13.6% avg upside
11 analysts
|
$160.00
2.25% Downside
|
+30.2% | · |
|
GB:OXB
Oxford BioMedica
|
Jul 15, 2025 | HOLD |
Buy
+53.5% avg upside
5 analysts
|
$400.00
12.81% Downside
|
+81.8% | · |
|
ES:GRF
Grifols
|
Jun 17, 2025 | HOLD |
Buy
+51.5% avg upside
13 analysts
|
$12.00
25.20% Upside
|
-12.2% | · |
|
GRFS
Grifols SA
|
Jun 17, 2025 | HOLD |
Buy
+223.2% avg upside
13 analysts
|
$10.30
39.90% Upside
|
-14.5% | · |
|
GB:0MGB
Genmab A/S
|
Jun 06, 2025 | HOLD |
Buy
-7.3% avg upside
25 analysts
|
$1500.00
33.90% Downside
|
+6.7% | · |
|
CH:IDIA
Idorsia Ltd
|
Dec 03, 2024 | HOLD |
Hold
-11.5% avg upside
9 analysts
|
$1.00
79.05% Downside
|
+258.7% | · |
|
NL:LKFT
Lakefront Biotherapeutics NV
|
Oct 23, 2024 | HOLD |
Sell
+93.5% avg upside
17 analysts
|
$29.00
11.99% Upside
|
+2.4% | · |
|
LKFT
Lakefront Biotherapeutics
|
Oct 22, 2024 | HOLD |
Buy
+237.6% avg upside
25 analysts
|
$32.00
8.21% Upside
|
+5.4% | · |
|
TAK
Takeda Pharmaceutical Company
|
Oct 09, 2024 | HOLD |
Strong Buy
+28.4% avg upside
6 analysts
|
$14.80
21.62% Downside
|
+0.9% | · |
|
SDZNY
Sandoz Group Ltd Sponsored ADR
|
May 08, 2024 | BUY |
Strong Buy
-49.5% avg upside
4 analysts
|
$44.38
47.76% Downside
|
+32.2% | · |
|
CH:ALC
Alcon
|
Nov 16, 2020 | HOLD |
Buy
+33.2% avg upside
36 analysts
|
$57.00
6.13% Upside
|
+31.0% | · |
|
CH:ROP
Roche Holding AG
|
May 14, 2020 | BUY |
Buy
-5.4% avg upside
24 analysts
|
$400.00
10.40% Upside
|
-11.7% | · |
|
HKMPY
Hikma Pharmaceuticals
|
Apr 02, 2020 | BUY |
Strong Buy
3 analysts
|
— | +14.0% | · |
|
GB:NIOX
Circassia Pharmaceuticals
|
Dec 29, 2017 | HOLD |
Buy
+6972.1% avg upside
2 analysts
|
$9336.37
13939.53% Upside
|
-47.1% | · |
|
GSK
GlaxoSmithKline
|
Aug 15, 2016 | HOLD |
Hold
-14.0% avg upside
20 analysts
|
— | -7.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.